Omega Healthcare stock analysis
Omega Healthcare (WX4) Stock Price & Analysis
WX4 Stock Chart & Stats
- Day’s Range
- EUR 43.10 - EUR 43.62
- 52-Week Range
- EUR 35.20 - EUR 46.00
- Previous Close
- EUR 43.21
- Volume
- N/A
- Average Volume (3M)
- 57
- Market Cap
- EUR 13.27B
- Enterprise Value
- EUR 18.93B
- Total Cash (Recent Filing)
- EUR 195.90M
- Total Debt (Recent Filing)
- EUR 4.02B
- Price to Earnings (P/E)
- 19.2
- Beta
- -0.06
- Next Earnings
- Feb 04, 2027 (Est.)
- EPS Estimate
- 0.46
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 5.51%
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue Growth
Accelerating revenue reflects stronger contributions from the operating portfolio and expanding investment activity. If sustained, higher recurring revenue can support property-level cash generation, strengthen coverage of corporate costs, and provide a durable base for future adjusted FFO growth.
Accretive Portfolio Repositioning
The PACS transaction demonstrates active portfolio management that can improve contractual rent and long-term internal growth. Its scheduled escalators and expected FAD accretion provide recurring earnings support, while the new operator relationship may strengthen the portfolio's operating platform.
Liquidity And Leverage Improvement
Strong liquidity and lower leverage improve Omega's ability to fund investments, address debt maturities, and manage fluctuations in operator performance. Ample revolver capacity and substantial fixed-charge coverage also provide flexibility to pursue healthcare real estate opportunities without immediate balance-sheet strain.
Bears Say
Material Absolute Debt Load
Although leverage ratios have improved, the sizable absolute debt balance leaves Omega dependent on reliable property cash flows and access to capital markets. If operating conditions weaken or financing becomes less available, debt service and refinancing needs could constrain acquisitions and other capital allocation.
Competitive Investment Pricing
More aggressive cap rates can compress acquisition yields and reduce the spread between investment returns and funding costs. Persistent competition may force greater selectivity, limit accretive deployment, or increase underwriting risk as Omega pursues growth across senior housing and UK care homes.
Maplewood Stabilization Risk
Maplewood's incomplete stabilization delays the property's ability to contribute fully to recurring cash flow and leaves performance dependent on occupancy improvement. The uncertain one-to-two-year timeline adds execution risk and could limit the near-term earnings benefit from the portfolio.
Omega Healthcare News
WX4 FAQ
What was Omega Healthcare’s price range in the past 12 months?
What is Omega Healthcare’s market cap?
When is Omega Healthcare’s upcoming earnings report date?
How were Omega Healthcare’s earnings last quarter?
Is Omega Healthcare overvalued?
Does Omega Healthcare pay dividends?
What is Omega Healthcare’s EPS estimate?
How many shares outstanding does Omega Healthcare have?
What happened to Omega Healthcare’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Omega Healthcare?
What is the TipRanks Smart Score and how is it calculated?
Omega Healthcare Stock Smart Score
Company Description
Omega Healthcare
Omega Healthcare Investors, Inc. functions as a Real Estate Investment Trust (REIT) primarily focused on the long-term healthcare sector. The company strategically invests in properties providing skilled nursing and assisted living services. A diverse array of healthcare operators manage these assets, predominantly utilizing a triple-net lease framework. Its portfolio is geographically distributed across all regions of the United States and also includes holdings in the United Kingdom.
- Sector
- Realestate
- Industry
- REIT - Healthcare Facilities
- CEO
- Matthew Gourmand
- Employees
- 69
- Website
- www.omegahealthcare.com
- Address
- 303 International Circle, Hunt Valley, MD, 21030, US
Omega Healthcare (WX4) Earnings & Revenues
WX4 Earnings Call
Earnings Call SentimentPositive
The call was broadly positive. Omega reported year-over-year AFFO growth, raised full-year guidance, deployed substantial capital into accretive transactions, resolved the Genesis situation, maintained strong liquidity and low leverage, and described its investment pipeline and operating fundamentals as strong. The main negatives were the sequentially flat AFFO and FAD, lower GAAP net income due to transaction-related expenses and the prior-year asset-sale gain, Maplewood's incomplete stabilization, competitive pricing, and potential longer-term regulatory uncertainty.
View all DE:WX4 earnings summariesWX4 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 3 | 5 |
| Technical Analysis | 2 | 3 | 5 |
| Moving Averages | 12 | 0 | 0 |











